ValiRx PLC (VAL)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.50p

Buy

0.55p

arrow-up0.00p (+0.00%)

ValiRx PLC is a biopharmaceutical company. It is engaged in developing technologies and products in oncology therapeutics and diagnostics focused on the treatment of cancer and associated Biomarkers, specializing in epigenomic and genetic analysis.

Prices updated at 16 May 2025, 16:13 BST

| Prices minimum 15 mins delay

|

Prices in GBX

FTSE All-Share

0.59%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	0.55p - 0.54p
	4.49p - 0.38p
	-
	1.97m
	-
	500,000
	611,194
	0.51
	3,613,483.67
	-1.00
	102.32m
	GB00BLH13C52
	-0.02
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Investment accounts

Adult accounts

Child accounts

Choosing Fidelity

Financial advice & support

Fidelity’s Services

Guides

Guidance and tools

Funds

Choose your funds

Tools and information

Shares

Share dealing

Choose your shares

Tools and information

Pensions & retirement

Pensions, tax & tools

Saving for retirement

Approaching / In retirement